ORAL DELIVERY OF MODIFIED TRANSFERRIN FUSION PROTEINS

Details for Australian Patent Application No. 2003270009 (hide)

Owner BIOREXIS PHARMACEUTICAL CORPORATION

Inventors PRIOR, Christopher, P.; SADEGHI, Homayoun; TURNER, Andrew

Pub. Number AU-A-2003270009

PCT Number PCT/US03/26778

PCT Pub. Number WO2004/019872

Priority 60/406,977 30.08.02 US; 10/378,094 04.03.03 US; 60/460,829 08.04.03 US

Filing date 28 August 2003

Wipo publication date 19 March 2004

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 60/406,977 30.08.02 US; 10/378,094 04.03.03 US; 60/460,829 08.04.03 US

6 May 2004 Application Open to Public Inspection

  Published as AU-A-2003270009

23 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003270010-TRANSFERRIN FUSION PROTEIN LIBRARIES

2003270008-ENDOLUMINAL DEVICE AND SYSTEM AND METHOD DETECTING A CHANGE IN PRESSURE DIFFERENTIAL ACROSS AN ENDOLUMINAL DEVICE